The author of a new guidebook on GLP-1s and other experts share their tips for how clinicians can optimize patient success ...

The US Food and Drug Administration has approved a drug that ... that will help manage weight in people with overweight or obesity and who have at least one weight-related condition, such as ...

The two main GLP-1 obesity drugs currently on the market ... which is approved by the US Food and Drug Administration to treat diabetes, but at a slightly higher dose, while Zepbound contains ...

A Medscape survey found that a strong majority of physicians believe high-risk patients should have easier access to new weight loss drugs.

Childhood obesity continues to be a growing problem in out country. So, should the government regulate food advertising like it did with cigarettes?

All things considered, it’s at least as likely to make health outcomes worse as it is to make most people healthier.

A front-of-package food label would be a great educational tool. The Trump administration should keep it.

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

That locked up the obesity drug. But after 9 Meters started ... Wegovy, for example, "doesn't really work" — at least to the Food and Drug Administration standard of weight loss of 5% or more ...

T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...